Patients with patent foramen ovale or atrial septal defect have worse outcomes after pulmonary vein isolation

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Mr Sandi Bajrami

Stony Brook (United States of America)

7 More presentations in this session

Presentation thumbnail

Hemolysis biomarkers after pulmonary vein isolation using three different pulsed-field ablation systems

Mr J. Bruegger (Basel, CH)

Abstract Slides Video

Presentation thumbnail

Is catheter ablation in atrial fibrillation patients with functional tricuspid regurgitation as effective as in patients with functional mitral regurgitation?

Doctor Y. Sumiyama (Nishinomiya, JP)

Abstract Slides Video

Presentation thumbnail

Bachmanns bundle related atrial tachycardias following catheter ablation of persistent atrial fibrillation

Doctor N. Christian-Miller (Ann Arbor, US)

Abstract Slides Video

Presentation thumbnail

Pulsed-field ablation versus radiofrequency ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis

Miss I. Martins Esteves (Porto, PT)

Abstract Slides Video

Presentation thumbnail

31 vs. 35 mm: pulsed-field ablation with two different-sized pentaspline catheters for the treatment of atrial fibrillation

Doctor C. Isenegger (Basel, CH)

Abstract Slides Video

Access the full session

Session thumbnail

Novel insights in catheter ablation of atrial fibrillation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Unsupervised machine learning of multimodal data to identify atrial fibrillation subgroups likely to benefit from pulmonary vein isolation

Congress Session

Catheter ablation in atrial fibrillation

Congress Session

Registries on atrial fibrillation and sudden death

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources